The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 58,416 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
ALLERGAN PLC | SHS | G0177J108 | 133,660 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
ALLERGAN PLC | SHS | G0177J108 | 133,660 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 43,746 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
AMAG PHARMACEUTICALS INC | COM | 00163U106 | 40,254 | 2,650,000 | SH | SOLE | 2,650,000 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 19,475 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 66,006 | 1,900,000 | SH | SOLE | 1,900,000 | 0 | 0 | ||
BAUSCH HEALTH COS INC | COM | 071734107 | 18,470 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 75,230 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 51,980 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
BROOKDALE SENIOR LIVING | COM | 112463104 | 50,250 | 7,500,000 | SH | SOLE | 7,500,000 | 0 | 0 | ||
CARDINAL HEALTH INC | COM | 14149Y108 | 44,600 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
CELGENE CORP | COM | 151020104 | 96,135 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 50,288 | 2,800,000 | SH | SOLE | 2,800,000 | 0 | 0 | ||
DAVITA INC | COM | 23918K108 | 8,621 | 167,528 | SH | SOLE | 167,528 | 0 | 0 | ||
EAGLE PHARMACEUTICALS INC | COM | 269796108 | 11,749 | 291,600 | SH | SOLE | 291,600 | 0 | 0 | ||
ENDOLOGIX INC | COM | 29266S106 | 6,659 | 9,300,000 | SH | SOLE | 9,300,000 | 0 | 0 | ||
GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 76,420 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS INC | COM | 37890U108 | 92,363 | 2,250,000 | SH | SOLE | 2,250,000 | 0 | 0 | ||
HCA HEALTHCARE INC | COM | 40412C101 | 31,113 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 96,661 | 875,000 | SH | SOLE | 875,000 | 0 | 0 | ||
MEDICINES CO | COM | 584688105 | 38,280 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 44,160 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
MYLAN N V | SHS EURO | N59465109 | 27,400 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
MYLAN N V | SHS EURO | N59465109 | 137,000 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 65,740 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
PERRIGO CO PLC | SHS | G97822103 | 85,250 | 2,200,000 | SH | SOLE | 2,200,000 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 26,455 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 38,196 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
SURGERY PARTNERS INC | COM | 86881A100 | 1,567 | 160,084 | SH | SOLE | 160,084 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 5,412 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
SYNTHORX INC | COM | 87167A103 | 32,364 | 1,862,116 | SH | SOLE | 1,862,116 | 0 | 0 | ||
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 55,705 | 3,250,000 | SH | SOLE | 3,250,000 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 207,900 | 2,800,000 | SH | SOLE | 2,800,000 | 0 | 0 | ||
UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 104,904 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 31,797 | 2,166,000 | SH | SOLE | 2,166,000 | 0 | 0 |